4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-19-012332
SVP & Chief Scientific Officer sold 3,310 shares at $42.39 ($140,311)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Doberstein Stephen K SVP & Chief Scientific Officer | 2019-02-19 | Sale | −3,310 | $42.39 | $140,311 | 99,374 | D |
| Open-market sales · 3,310 sh · avg $42.39 · $140,311 | |||||||
Loading xslF345X03/doc4.xml…